DOR BioPharma Inc., of Ewing, N.J., said CEO Christopher J. Schaber has been elected to the board of directors of BioNJ, the trade association for New Jersey bioscience companies. An item in BioWorld Today, March 9, 2009, about an appointment for Schaber was incorrect.

Editor's note: The correction has been made in BioWorld Online.